118 related articles for article (PubMed ID: 38507352)
1. Expression of Concern: Synaptic Dysbindin-1 Reductions in Schizophrenia Occur in an Isoform-Specific Manner Indicating Their Subsynaptic Location.
PLOS ONE Editors
PLoS One; 2024; 19(3):e0301152. PubMed ID: 38507352
[No Abstract] [Full Text] [Related]
2. Synaptic dysbindin-1 reductions in schizophrenia occur in an isoform-specific manner indicating their subsynaptic location.
Talbot K; Louneva N; Cohen JW; Kazi H; Blake DJ; Arnold SE
PLoS One; 2011 Mar; 6(3):e16886. PubMed ID: 21390302
[TBL] [Abstract][Full Text] [Related]
3. Dysbindin-1 in dorsolateral prefrontal cortex of schizophrenia cases is reduced in an isoform-specific manner unrelated to dysbindin-1 mRNA expression.
Tang J; LeGros RP; Louneva N; Yeh L; Cohen JW; Hahn CG; Blake DJ; Arnold SE; Talbot K
Hum Mol Genet; 2009 Oct; 18(20):3851-63. PubMed ID: 19617633
[TBL] [Abstract][Full Text] [Related]
4. Lack of change in markers of presynaptic terminal abundance alongside subtle reductions in markers of presynaptic terminal plasticity in prefrontal cortex of schizophrenia patients.
Fung SJ; Sivagnanasundaram S; Weickert CS
Biol Psychiatry; 2011 Jan; 69(1):71-9. PubMed ID: 21145444
[TBL] [Abstract][Full Text] [Related]
5. Dysbindin-1, a schizophrenia-related protein, functionally interacts with the DNA- dependent protein kinase complex in an isoform-dependent manner.
Oyama S; Yamakawa H; Sasagawa N; Hosoi Y; Futai E; Ishiura S
PLoS One; 2009; 4(1):e4199. PubMed ID: 19142223
[TBL] [Abstract][Full Text] [Related]
6. Reduced DTNBP1 (dysbindin-1) mRNA in the hippocampal formation of schizophrenia patients.
Weickert CS; Rothmond DA; Hyde TM; Kleinman JE; Straub RE
Schizophr Res; 2008 Jan; 98(1-3):105-10. PubMed ID: 17961984
[TBL] [Abstract][Full Text] [Related]
7. Dysbindin-1, a schizophrenia-related protein, interacts with HDAC3.
Soma M; Wang M; Suo S; Ishiura S
Neurosci Lett; 2014 Oct; 582():120-4. PubMed ID: 25196196
[TBL] [Abstract][Full Text] [Related]
8. Increased dysbindin-1B isoform expression in schizophrenia and its propensity in aggresome formation.
Xu Y; Sun Y; Ye H; Zhu L; Liu J; Wu X; Wang L; He T; Shen Y; Wu JY; Xu Q
Cell Discov; 2015; 1():15032. PubMed ID: 27462430
[TBL] [Abstract][Full Text] [Related]
9. Regulation of Brain-Derived Neurotrophic Factor Exocytosis and Gamma-Aminobutyric Acidergic Interneuron Synapse by the Schizophrenia Susceptibility Gene Dysbindin-1.
Yuan Q; Yang F; Xiao Y; Tan S; Husain N; Ren M; Hu Z; Martinowich K; Ng JS; Kim PJ; Han W; Nagata KI; Weinberger DR; Je HS
Biol Psychiatry; 2016 Aug; 80(4):312-322. PubMed ID: 26386481
[TBL] [Abstract][Full Text] [Related]
10. Correlated alterations in serotonergic and dopaminergic modulations at the hippocampal mossy fiber synapse in mice lacking dysbindin.
Kobayashi K; Umeda-Yano S; Yamamori H; Takeda M; Suzuki H; Hashimoto R
PLoS One; 2011 Mar; 6(3):e18113. PubMed ID: 21448290
[TBL] [Abstract][Full Text] [Related]
11. Dysbindin-1 modifies signaling and cellular localization of recombinant, human D₃ and D₂ receptors.
Schmieg N; Rocchi C; Romeo S; Maggio R; Millan MJ; Mannoury la Cour C
J Neurochem; 2016 Mar; 136(5):1037-51. PubMed ID: 26685100
[TBL] [Abstract][Full Text] [Related]
12. Loss of Dysbindin Implicates Synaptic Vesicle Replenishment Dysregulation as a Potential Pathogenic Mechanism in Schizophrenia.
Hu H; Wang X; Li C; Li Y; Hao J; Zhou Y; Yang X; Chen P; Shen X; Zhang S
Neuroscience; 2021 Jan; 452():138-152. PubMed ID: 33186610
[TBL] [Abstract][Full Text] [Related]
13. The schizophrenia susceptibility gene dysbindin controls synaptic homeostasis.
Dickman DK; Davis GW
Science; 2009 Nov; 326(5956):1127-30. PubMed ID: 19965435
[TBL] [Abstract][Full Text] [Related]
14. Dysbindin regulates hippocampal LTP by controlling NMDA receptor surface expression.
Tang TT; Yang F; Chen BS; Lu Y; Ji Y; Roche KW; Lu B
Proc Natl Acad Sci U S A; 2009 Dec; 106(50):21395-400. PubMed ID: 19955431
[TBL] [Abstract][Full Text] [Related]
15. Acute stress in adolescence vs early adulthood following selective deletion of dysbindin-1A: Effects on anxiety, cognition and other schizophrenia-related phenotypes.
Desbonnet L; O'Tuathaigh CM; O'Leary C; Cox R; Tighe O; Petit EI; Wilson S; Waddington JL
J Psychopharmacol; 2019 Dec; 33(12):1610-1619. PubMed ID: 31556815
[TBL] [Abstract][Full Text] [Related]
16. Dysbindin modulates prefrontal cortical glutamatergic circuits and working memory function in mice.
Jentsch JD; Trantham-Davidson H; Jairl C; Tinsley M; Cannon TD; Lavin A
Neuropsychopharmacology; 2009 Nov; 34(12):2601-8. PubMed ID: 19641486
[TBL] [Abstract][Full Text] [Related]
17. Impaired autophagy in hilar mossy cells of the dentate gyrus and its implication in schizophrenia.
Yuan Y; Wang H; Wei Z; Li W
J Genet Genomics; 2015 Jan; 42(1):1-8. PubMed ID: 25619597
[TBL] [Abstract][Full Text] [Related]
18. The schizophrenia susceptibility gene DTNBP1 modulates AMPAR synaptic transmission and plasticity in the hippocampus of juvenile DBA/2J mice.
Orozco IJ; Koppensteiner P; Ninan I; Arancio O
Mol Cell Neurosci; 2014 Jan; 58():76-84. PubMed ID: 24321452
[TBL] [Abstract][Full Text] [Related]
19. Dysbindin-1 contributes to prefrontal cortical dendritic arbor pathology in schizophrenia.
Konopaske GT; Balu DT; Presti KT; Chan G; Benes FM; Coyle JT
Schizophr Res; 2018 Nov; 201():270-277. PubMed ID: 29759351
[TBL] [Abstract][Full Text] [Related]
20. The Proteome of BLOC-1 Genetic Defects Identifies the Arp2/3 Actin Polymerization Complex to Function Downstream of the Schizophrenia Susceptibility Factor Dysbindin at the Synapse.
Gokhale A; Hartwig C; Freeman AH; Das R; Zlatic SA; Vistein R; Burch A; Carrot G; Lewis AF; Nelms S; Dickman DK; Puthenveedu MA; Cox DN; Faundez V
J Neurosci; 2016 Dec; 36(49):12393-12411. PubMed ID: 27927957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
